A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults
Maponga TG. et al, (2025), Annals of Hepatology, 30, 101763 - 101763
Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses
Delphin M. et al, (2025), Journal of Infection, 91, 106514 - 106514
HIV PrEP programmes as a framework for diagnosing and treating HBV infection in adolescents and young adults in KwaZulu-Natal, South Africa
Sukali G. et al, (2025), Journal of Virus Eradication, 100600 - 100600
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Zwerwer LR. et al, (2025), Nature Communications, 16
Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call
Li Y. et al, (2025), eClinicalMedicine, 83, 103234 - 103234
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field
Lumley SF. et al, (2025), The Lancet Microbe, 101076 - 101076
Impact of metformin on HBV replication: No evidence of suppression in vitro
Hawkins C. et al, (2025), Journal of Clinical Virology, 177, 105781 - 105781
Infecting minds: socio-contextual drivers of vaccine perceptions and attitudes among young and older adults living in urban and rural areas in KwaZulu-Natal, South Africa
Orievulu KS. et al, (2025), BMC Public Health, 25
Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms
Lumley SF. et al, (2025), Scientific Reports, 15
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families
Jemutai J. et al, (2025), The Lancet Gastroenterology & Hepatology, 10, 100 - 103
Pathogens don't respect politicians: US federal disruption poses a new threat to global public health
Wang S. et al, (2025), The Lancet Gastroenterology & Hepatology
Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
Matthews PC. et al, (2025), JHEP Reports, 7, 101280 - 101280
Knowledge, attitudes and practices to hepatitis B among South African primary healthcare staff
Mashilo A. et al, (2025), African Journal of Primary Health Care & Family Medicine, 17
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study
Swets MC. et al, (2024), JMIR Public Health and Surveillance, 10, e55376 - e55376
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
Pritchard E. et al, (2024), American Journal of Epidemiology, 193, 1848 - 1860
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir
Lumley SF. et al, (2024), Journal of Clinical Virology, 174, 105711 - 105711
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711.
Lumley SF. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 174
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos/tide analogue therapy
Wang T. et al, (2024), JHEP Reports, 101229 - 101229